Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marsden

Showing results (711-720 of 1,014) with videos related to

Pageof 102
Sort By:
Psychopharmacology|February 1, 1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmosetK K Gnanalingham, D D Erol, A J Hunter, et al.
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.
Brain : a Journal of Neurology|April 1, 1992
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's diseaseV M Mann, J M Cooper, D Krige, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?H Meierkord, D R Fish, S J Smith, et al.
The Journal of Physiology|September 1, 1991
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in manY Ugawa, B L Day, J C Rothwell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1976
Bromocriptine treatment in Parkinson's diseaseJ D Parkes, C D Marsden, I Donaldson, et al.
Neuroscience Letters|June 18, 1986
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigraA J Bradbury, B Costall, A M Domeney, et al.
Structural Dynamics (Melville, N.Y.)|March 28, 2017
Partial-occupancy binders identified by the Pan-Dataset Density Analysis method offer new chemical opportunities and reveal cryptic binding sitesNicholas M Pearce, Anthony R Bradley, Tobias Krojer, et al.
Pageof 102

Showing results (711-720 of 1,014) with videos related to

Sort By:
Pageof 102
Psychopharmacology|February 1, 1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmosetK K Gnanalingham, D D Erol, A J Hunter, et al.
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.
Brain : a Journal of Neurology|April 1, 1992
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's diseaseV M Mann, J M Cooper, D Krige, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?H Meierkord, D R Fish, S J Smith, et al.
The Journal of Physiology|September 1, 1991
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in manY Ugawa, B L Day, J C Rothwell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1976
Bromocriptine treatment in Parkinson's diseaseJ D Parkes, C D Marsden, I Donaldson, et al.
Neuroscience Letters|June 18, 1986
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigraA J Bradbury, B Costall, A M Domeney, et al.
Structural Dynamics (Melville, N.Y.)|March 28, 2017
Partial-occupancy binders identified by the Pan-Dataset Density Analysis method offer new chemical opportunities and reveal cryptic binding sitesNicholas M Pearce, Anthony R Bradley, Tobias Krojer, et al.
Pageof 102